Researchers at the University of Virginia School of Medicine have discovered a specific group of brainstem nerve cells that regulates blood pressure stability, revealing that normal average readings can mask dangerous moment-to-moment fluctuations caused by the loss of these cellular controls.
In Plain English: The Clinical Takeaway
- Beyond Averages: Standard blood pressure cuffs measure average pressure, but rapid swings between sleeping, standing, or exercising can occur independently and strain the cardiovascular system.
- Cellular Control: A small population of several hundred neurons in the brainstem acts as a natural stabilizer to limit sharp blood pressure swings during daily transitions.
- Clinical Implications: The findings point toward future therapies focused on maintaining constant blood pressure stability rather than solely pushing down average numerical targets.
Unstable Blood Pressure Despite Normal Readings
Blood pressure evaluations typically rely on average values. However, growing evidence suggests that rapid or excessive pressure changes throughout the day can independently elevate the risk of stroke, heart disease, and brain injury, even when standard average measurements sit in the normal range.
To investigate the physiological drivers behind these variations, researchers at the University of Virginia School of Medicine examined how the brainstem helps maintain steady blood pressure. Their laboratory findings isolate a distinct population of nerve cells in the brainstem responsible for limiting blood pressure swings as individuals transition between fundamental daily activities like sleeping, waking, standing, and exercising.
Stephen Abbott, PhD, and his team observed that the loss of just a few hundred of these specialized neurons triggers unstable blood pressure swings. These fluctuations persist despite normal average readings, demonstrating that the biological machinery keeping blood pressure steady from moment to moment has failed.
“What we found is that a loss of just a few hundred nerve cells leads to unstable blood pressure even though the mean blood pressure was normal,” said UVA’s Stephen Abbott, PhD, the lead investigator of the study. “This shows that the system that keeps blood pressure steady from moment to moment is no longer working.”
Cellular Mechanisms and Neurological Overlaps
The newly studied brainstem nerve cells share a direct biological connection to severe neurodegenerative pathology. Previously published investigations have established that these exact same neurons suffer damage or disappear entirely in patients diagnosed with multiple system atrophy, a rare and fatal neurological disorder related to Parkinson’s disease. Individuals with multiple system atrophy frequently experience severe difficulties with blood pressure regulation.
The latest discovery suggests that similar cellular disruptions within the brainstem may contribute to unstable blood pressure across other clinical conditions, including cases where standard diagnostic metrics show normal average levels. Identifying this core mechanism opens new avenues for therapeutic intervention.
“Our work emphasizes a new appreciation for how we think about blood pressure problems,” Abbott said. “It’s not just about lowering the numbers – it’s about keeping blood pressure stable from moment to moment.”
Research Funding and Collaborative Discovery
The findings were detailed in the scientific journal Circulation Research. The study was authored by George M.P.R. Souza, Harsha Thakkalapally, Faye E. Berry, Leah F. Wisniewski, Ulrich M. Atongazi, Daniel S. Stornetta, and Stephen Abbott.
| Research Parameter | Details |
|---|---|
| Lead Institution | University of Virginia School of Medicine |
| Primary Funding Source | National Institutes of Health (Grant HL148004) |
| Financial Disclosures | The researchers reported no financial interests related to the study. |
| Institutional Affiliation | UVA’s Paul and Diane Manning Institute of Biotechnology |
The research team reported no financial interests related to the study. Financial backing was provided by the National Institutes of Health through grant HL148004. This discovery also reflects the broader goals of UVA’s newly established Paul and Diane Manning Institute of Biotechnology, which focuses on advancing research into difficult and complex diseases while helping promising laboratory findings move more quickly toward potentially lifesaving treatments for patients.
References
- Funding was provided by the National Institutes of Health through grant HL148004.
Related reading
